Hepatocellular carcinoma (HCC) is a leading cause of cancer-related death, and external beam radiation therapy has emerged as a promising approach for managing HCC. Proton beam therapy (PBT) offers dosimetric advantages over X-ray therapy, with superior physical properties known as the Bragg peak. PBT holds promise for reducing hepatotoxicity and allowing safe dose-escalation to the tumor. It has been tried in various clinical conditions and has shown promising local tumor control and survival outcomes. A recent phase III trial demonstrated the non-inferiority of PBT in local tumor control compared to current standard radiofrequency ablation in early-stage HCC. PBT also tended to show more favorable outcomes compared to transarterial chemoembolization in the intermediate stage, and has proven effective in-field disease control and safe toxicity profiles in advanced HCC. In this review, we discuss the rationale, clinical studies, optimal indication, and future directions of PBT in HCC treatment.
Citations
Citations to this article as recorded by
The Rac1-USP11 feedback amplification loop: a radiation-activated engine driving radioresistance in hepatocellular carcinoma Kaixiao Zhou, Yabo Jiang, Jiahao Guo, Haobo Zhang, Yuhao Hu, Xuanyu Meng, Yecheng Li, Shaohua Wei, Jian Wang, Xubiao Wei, Shuqun Cheng, Jianping Cao, Yang Jiao British Journal of Cancer.2026; 134(3): 391. CrossRef
From Photons to Protons in Gastrointestinal Cancers: A Journey of Transition, Awe, Challenge, and Renewed Hope Ashu Abhishek International Journal of Particle Therapy.2026; 19: 101299. CrossRef
Tailored proton beam therapy for hepatocellular carcinoma: Addressing unmet needs through a multidisciplinary approach Jeong Ha Lee, Nalee Kim, Jeong Il Yu, Hee Chul Park, Sungkoo Cho, Byeong Geun Song, Myung Ji Goh, Wonseok Kang, Dong Hyun Sinn, Geum-Youn Gwak, Joon Hyeok Lee, Yong-Han Paik, Moon Seok Choi, Minsuk Kwon, Jung Yong Hong, Gyu-Seong Choi, Woo Kyoung Jeong, M European Journal of Cancer.2026; 237: 116593. CrossRef
Current Advances in Proton FLASH Radiotherapy in Abdominal Cancers Xiao Wang, Yin Zhang, Xinxin Zhang, Zhenyu Xiong, Keying Xu, Ning J. Yue, Chi Ma Cancers.2026; 18(5): 758. CrossRef
Should we prioritize proton beam therapy before making a decision on orthotopic liver transplantation for unresectable hepatoblastoma? Yi-Wen Hsiao, Yi-Lun Wang, Chen-Kan Tseng, Tsung-Yen Chang, Shih-Hsiang Chen, Tang-Her Jaing The Turkish Journal of Pediatrics.2026; : 1. CrossRef
Artificial intelligence-enhanced Couinaud segmentation for precision liver cancer therapy Liang Qiu, Wenhao Chi, Xiaohan Xing, Praveenbalaji Rajendran, Mingjie Li, Yuming Jiang, Oscar Pastor-Serrano, Sen Yang, Yuanfeng Ji, Qiang Wen Biomedical Signal Processing and Control.2026; 120: 110100. CrossRef
Comparison of Prognostic Outcomes Between Repeat Liver Resection and Particle Therapy for Patients with Recurrent Hepatocellular Carcinoma Tatsuki Kusuhara, Hidetoshi Gon, Kazuki Terashima, Shohei Komatsu, Yoshiro Matsuo, Sunao Tokumaru, Hirochika Toyama, Masahiro Kido, Tomoaki Okimoto, Takumi Fukumoto Annals of Surgical Oncology.2025; 32(2): 1073. CrossRef
Hepatocellular carcinoma: updates on epidemiology, surveillance, diagnosis and treatment Soo Young Hwang, Pojsakorn Danpanichkul, Vatche Agopian, Neil Mehta, Neehar D. Parikh, Ghassan K. Abou-Alfa, Amit G. Singal, Ju Dong Yang Clinical and Molecular Hepatology.2025; 31(Suppl): S228. CrossRef
Efficacy and safety of radiotherapy combined with immune checkpoint inhibitors for advanced or unresectable hepatocellular carcinoma: A systematic review and meta-analysis Qibin Wu, Xia Zhao, Chong Yang, Yinglin Yuan, Hongji Yang, Qiang Fu Critical Reviews in Oncology/Hematology.2025; 211: 104730. CrossRef
Proton beam therapy in the management of hepatocellular carcinoma Kenneth S. H. Chok, Tiffany Y. T. Joeng, Darren M. C. Poon Expert Review of Gastroenterology & Hepatology.2025; 19(5): 495. CrossRef
Combination of radiotherapy and ICIs in advanced hepatocellular carcinoma: A systematic review of current evidence and future prospects (Review) Cheng Ma, Xinlin Yu, Xialin Zhang, Lihong Su, Ou Jiang, Ran Cui Oncology Letters.2025; 30(1): 1. CrossRef
Multidisciplinary strategies including local treatment to achieve drug‑free status after atezolizumab plus bevacizumab treatment in hepatocellular carcinoma Nobuaki Ishihara, Shohei Komatsu, Yoshihiko Yano, Yoshimi Fujishima, Jun Ishida, Masahiro Kido, Hidetoshi Gon, Kenji Fukushima, Takeshi Urade, Hiroaki Yanagimoto, Hirochika Toyama, Yuzo Kodama, Takumi Fukumoto Oncology Letters.2025; 30(4): 1. CrossRef
Current application status of proton beam therapy for gastrointestinal tumors Jingwen Zhang, Han Zhou, Benxin Zhao, Tian Liu, Chang Guo, Wenjing Fei, Zetian Shen Oncologie.2025; 27(6): 855. CrossRef
A contrast‑enhanced CT histogram‑driven nomogram for predicting post‑radiotherapy liver regeneration in hepatocellular carcinoma Bo Liu, Yuan Xu, Xijie Zhang, Wei Qi, Bo Ren, Wenjia Kong, Wence Zhou Radiation Oncology.2025;[Epub] CrossRef
Highly permeable and tumor-selective killing Doxil for efficient cancer therapy Yidan Shen, Yiyang Sun, Yangla Xie, Yanpeng Liu, Zile Shao, Siyu Chen, Zhengxing Lian, Chang Xu, Fei Lv, Jinyi Tong, Youqing Shen, Nasha Qiu Nano Research.2025; 18(12): 94907987. CrossRef
Intrahepatic IgA complex induces polarization of cancer-associated fibroblasts to matrix phenotypes in the tumor microenvironment of HCC Jong Geun Park, Pu Reun Roh, Min Woo Kang, Sung Woo Cho, Suhyun Hwangbo, Hae Deok Jung, Hyun Uk Kim, Ji Hoon Kim, Jae-Sung Yoo, Ji Won Han, Jeong Won Jang, Jong Young Choi, Seung Kew Yoon, Young Kyoung You, Ho Joong Choi, Jae Yong Ryu, Pil Soo Sung Hepatology.2024; 80(5): 1074. CrossRef
Clinical outcomes and safety of external beam radiotherapy with extensive intrahepatic targets for advanced hepatocellular carcinoma: A single institutional clinical experience Sunmin Park, Chai Hong Rim, Won Sup Yoon Saudi Journal of Gastroenterology.2024; 30(6): 399. CrossRef
Novel paradigm in the treatment of hepatocellular carcinoma: Anticipating breakthroughs with particle therapy Sang Min Yoon Clinical and Molecular Hepatology.2023; 29(4): 977. CrossRef
First
Prev
